Biological E to start phase-III trials by January, license vaccine by summer

Disclosing this in Hyderabad on Monday, managing director Mahima Datla
said the company is currently evaluating four different formulations
depending on different antigen strengths in the phase I-II combined
studies.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biological-e-to-start-phase-iii-trials-by-january-license-vaccine-by-summer/articleshow/79382405.cms

Comments

Popular posts from this blog

IBSD MSc Biotech & Life Sciences Research Fellow Post

Clinical Data Manager Job Opening @ Novartis- Apply Now